Prevention of Pneumocystis carinii pneumonia in cardiac transplant recipients by trimethoprim sulfamethoxazole

Pneumocystis carinii pneumonia (PCP) continues to cause significant morbidity in recipients of solid-organ transplants. While some programs administer trimethoprim-sulfamethoxazole (TMP-SMX) prophylactically following transplantation, a prospective determination of the safety and efficacy of TMP-SMX...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Transplantation 1993-08, Vol.56 (2), p.359-362
Hauptverfasser:	OLSEN, S. L, RENLUND, D. G, O'CONNELL, J. B, TAYLOR, D. O, LASSETTER, J. E, EASTBURN, T. E, HAMMOND, E. H, BRISTOW, M. R
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antibiotics. Antiinfectious agents. Antiparasitic agents Antiparasitic agents Biological and medical sciences Drug Administration Schedule Female Follow-Up Studies Heart Transplantation - adverse effects Humans Immunosuppressive Agents - therapeutic use Male Medical sciences Middle Aged Opportunistic Infections - microbiology Opportunistic Infections - prevention & control Pharmacology. Drug treatments Pneumocystis carinii Pneumonia, Pneumocystis - prevention & control Prospective Studies Transplantation, Homologous Trimethoprim, Sulfamethoxazole Drug Combination - administration & dosage Trimethoprim, Sulfamethoxazole Drug Combination - adverse effects Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!